Finance entity
earnings is the sole category represented across all 1 tracked stories. Interventional MRI is most often covered alongside OptimizeRx Corp., which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.3 in the same window.
Last mentioned: Mar 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Interventional MRI is most often covered alongside OptimizeRx Corp., which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. We currently track 1 Finance story that mention Interventional MRI, all published on March 6, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Interventional MRI. Shared-story counts are live from our verified record — not editorial picks.
Profound Medical and OptimizeRx reported robust fourth-quarter and full-year 2025 financial results, signaling a significant uptick in the adoption of MRI-guided interventions and digital life sciences engagement. The reports highlight a broader recovery in healthcare technology spending and a shift toward precision-based medical outcomes.
Interventional MRI is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
